The novel approach of the medication represents a major development in the care of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide impacts multiple pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatide-peptide871432.blogitright.com/42419396/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment